Open Access
Subscription Access
Review on Nanoprobe Device in Pharmaceutical
Abstract
This analysis efforts on the visualization, imaging, and detecting of diseases using nanoprobes. Various currently used nanoprobes are described, including fluorescent nanoprobes, upconversion nanoparticle probes, super magnetic iron oxide nanoprobes, polymer- and liposome-based nanoprobes, and others. The methods utilized to image and track single cells, tumours, cancer cells, brain disorders, and angiogenic vasculature are also briefly summarized in this publication. Additionally, future research directions and current problems are highlighted. The development of stimuli-responsive, activated nanoprobes for Tumor-specific delivery and diagnosis has significantly increased in the field of nanomedicine. There are specific features of the Tumor microenvironment that can be used to develop therapeutic approaches based on changes between normal tissues and Tumor tissues, such as variations in pH, oxygenation, enzyme expression, gene activation/inactivation, and vasculature. When activated nanoparticles reach the Tumor site, they are altered by specific tumoral stimuli, causing a medication or other substance to be released from the nanocarriers of the activated nanoparticles. In terms of novel design approaches and applications, this review illustrates the most recent developments in the usage of internal stimuli-responsive, activatable nanoparticles.
References
Mazumder, S.; Pavurala, N. A review on nanoprobes for sensing, imaging and disease detection. J. mater Sci. Nanotechnology. 2016, 4, 1
Thiruppathi; Mishra, S.; Ganapathy, M.; Padmanabhan, P.; Gulyás, B. Nanoparticle functionalization and Its potentials for molecular imaging. Adv. Sci. 2016
D.J. Bharali et a Pharmacol. The
M.A. Phillips et al.Nano Today (2010)
D. E. Bloom, D. Cadarette, Infectious disease Threats in the twenty-¯rst century: Strengthening The global response,” Front. Immunol. 10, 549 (2019).
D. Puri, Y. B. Nisar, A. Tshefu, A.Longombe,F. Esamai, I. Marete, A. I. Ayede, E. A. Adejuyigbe, R D. Wammanda, S. A. Qazi, R. Bahl, “Prevalence ofClinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of youn infants from birth to 2 months of age,” PLoS ONE 16(2), e0247457 (2021).
C. A. Devaux, O. Mediannikov, H. Medkour, D. Raoult /Infectious disease risk across the growing Human-non human primate interface: A review of The evidence,”Front. Public Health 7, 305 (2019)
J. Munguia, V. Nizet, Pharmacological targeting of the host–pathogen interaction: Alternatives toClassical antibiotics to combat drug-resistant Superbugs,” Trends Pharmacol. Sci. 38(5), 473–488 (2017).
A. Gupta, S. Mumtaz, C.-H. Li, I. Hussain, V. M.Rotello, Combatting antibiotic-resistant bacteria Using nanomaterials,” Chem. Soc. Rev. 48(2), 415–427 (2012).
E. Christaki, M. Marcou, A. Towards, AntimicrobialResistance in bacteria: Mechanisms, evolution, and Persistence,” J. Mol. Evol. 88(1), 26–40 (2020).
E. Peterson, P. Kaur, Antibiotic resistance in Mechanisms bacteria: Relationship between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens,” Front. Microbiol. 9, 2928 (2018)
S.S. Agasti et al. Adv. Drug Deliv. Rev. (2010).
Jang, J.K.; Canter, D.; Hu, P.; Epstein, A.L.; Khawli, L.A. Labeling and imaging techniques for quantification of therapeutic biologics. In Pharmaceutical Sciences Encyclopedia; John Wiley & Sons, Inc.: New York, NY, USA, 2010; pp. 1–24.
H. Maeda et al.J. Control. Release (2000)
K. Kim et al.J. Control. Release (2010)
H. Kim et al.J. Control. Release (2010)
Caruso F, Hyeon T, Rotello VM. Chem Soc Rev. 2012; 41:2537–8.
J.-H. Kim et al. Prog. Polym. Sci. (2007)
Y.T. Lim et al. Biomaterials (2010)
J.-J. Lin et al. Biomaterials (2009)
D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nat. Nanotechnol. 2(12), 751–760 (2007).
Wu, Hui-Fen; Agrawal, Kavita; Shrivas, Kamlesh; Lee, Yi-Hsien (2010). "On particle ionization/enrichment of multifunctional nanoprobes: Washing/separation-free, acceleration and enrichment of microwave-assisted tryptic digestion of proteins via bare TiO2 nanoparticles in ESI-MS and comparing to MALDI-MS". Journal of Mass Spectrometry. 45 (12): 1402–8. Bibcode:2010JMSp...45.1402W. doi:10.1002/jms.1855. PMID 20967754.
Khandelwal, Purnima; Beyer, Chad E.; Lin, Qian.
G.A. Pang, J. Laufer, R. Niessner, C. Haisch, Photocoustic signal generation in gold6 nanospheres in aqueous solution: Signal generation enhancement and particle diameter enhancement, J. phys. Chem. C 120 (48), 27646-27656 (2016).
L.R. Holt, B. J. Plowman, N. P. Young, k.Tschulik , R.G. Compton, The electrochemical characterization of single core-shell nanoparticles, Angew. Chem., Int. Ed.
K. Kostarelos, A. Bianco, M. Prato, Promises, facts, and challenges for carbon nanotubes in imaging and therapeutics," Nat. Nanotechnology. 4(10), 627–633 (2009).
H. Gong, R. Peng, Z. Liu, Carbon nanotubes for biomedical imaging: The recent advances," Adv. Drug Deliv. Rev.
Z. Liu, K. Yang, S.-T. Lee, “Single-walled carbon nanotubes in biomedical imaging,” J. Mater. Chem.
A. E. Porter, M. Gass, K. Muller, J. N. Skepper, P. A. Midgley, M. Welland, “Direct imaging of single-walled carbon nanotubes in cells,” Nat. Nanotechnology.
van Vlerken LE, Vyas TK and Amii MM: Poly (ethylene glycol)-modified nanocarriers for Tumor-targeted and intracellular delivery. Pharm Res. 24:1405–1414. 2007.
Biswas AK, Islam R, Choudhury ZS, Mostafa A and Kadir MF: Nanotechnology based approaches in cancer therapeutics. Adv Nat SciNanosci Nanotechnology. 5:2043–6262. 2004.
Das A, Mukherjee P, Singla SK, Guturu P, Frost MC, Mukhopadhyay D, Shah VH and Patra CR: Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide. Nanotechnology. 21(305102)2010.
Brede C, Labhasetwar V (2013) Applications of nanoparticles in the detection and treatment of kidney diseases. Adv Chronic Kidney Dis 20(6):454–465.
Chen D, Han S, Zhu Y, Hu F, Wei Y, Wang G (2018) Kidney-targeted drug delivery via Rhein-loaded polyethylene glycol-co-polycaprolactone-co-polyethyleneimine nanoparticles for diabetic nephropathy therapy. Int J Nano med 13:3507–3527.
Galperin S, Kisich K, Iseman MD, Heifetz L (2005) The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 172(12):1487–1490.
Jeon HS, Seo JE, Kim MS, Kang MH, Oh DH, Jeon SO, Jeong SH, Choi YW, Lee S (2013) A retinyl palmitate-loaded solid lipid nanoparticle system: effect of surface modification with diacetyl phosphate on skin permeation in vitro and anti-wrinkle effect in vivo. Int J Pharm 452(1–2):311–320.
Roney C et al (2005) Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer’s disease. J Control Release 108(2–3):193–214.
Wang M, Abbenineni G, Clevenger A, Mao C, Xu S (2011) Upconversion nanoparticles: synthesis, surface modification and biological application. nanomedicine 7:710-29.
Yu XF, Sun Z, Xiang Y, Wang QQ, et al. (2010) Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors Under near-infrared irradiation. biomaterials 33:8724-31.
Rong G, Corrie SR, Clark HA. 2017. In vivo biosensing: progress and perspectives. ACS Sens. 2: 327–38.
Pantelopoulos A, Bourbakis NG. 2010. A survey on wearable sensor-based systems for health monitoring and prognosis. IEEE Trans. Syst. Man Cobern. C 40: 1–12.
Song S, Qin Y, He Y, Huang Q, Fan C, Chen HY. 2010. Functional nanoprobes for ultrasensitive detection of biomolecules. Chem. Soc. Rev. 39: 4234–43.
Refbacks
- There are currently no refbacks.